WHAT YOU NEED TO KNOW: CANCER AWARENESS MONTH

GCC APril Blog 2

Cancer awareness month has its origin in the 1980’s when a small grassroots organization, Susan G. Komen, was formed to raise money and public awareness for breast cancer. The group created the now famous pink ribbon in order to create “brand awareness” for breast cancer and to generate much needed funding for cancer research, early detection and ultimately the diseases eventual cure.

The breast cancer program’s success spawned an important and growing expansion of the awareness campaign to cancers across the diseases spectrum. Many non-profit cancer organizations have gravitated towards the goals of the program and have originated specific colors and month of the year to represent their individual identities. The month of May represents three brands of cancers; Brain Cancer, Melanoma/ Skin Cancer and Bladder Cancer.

Brain tumors are growths of abnormal cells in tissues which originate in the brain or spinal cord. Tumors may be benign or malignant and affect nearby areas of the head and neck but rarely spread to other parts of the body. Symptoms vary and are dependent upon where the tumor forms, its size, how fast it is growing, and the age of the patient. More than 150,000 people are living with brain cancer with less than one percent of men and women likely to experience brain and nervous system cancer in their lifetime. Nearly 34 percent of brain cancer victims can expect to survive five years or more with early detection and aggressive treatment. Brain cancer is an extremely complex disease requiring a team of multi specialists including oncologist, primary care physicians and radiation oncologist. Each patient treatment protocol depends on the location of the tumor, its size and type, the patient’s age, and the overall medical condition of the patient. Brain Cancer is represented by the color grey in the month of May.

Melanoma, represented by the color black, is the most dangerous form of skin cancer and is most often caused by over exposure to ultraviolet radiation from sunshine or tanning beds. Cancerous growths develop when unrepaired DNA damage to skin cells initiate mutations that multiply rapidly and form malignant tumors. Discovered in its early stages and treated, skin cancer is almost always curable. But left untreated it can advance and spread to other parts of the body, where it becomes hard to treat and can be fatal. Depending on the stage of the disease treatments may include; surgery, immunotherapy, targeted therapy, chemotherapy and radiation.

Bladder Cancer originates when healthy cells in the bladder lining change and grow rapidly forming a tumor. Malignant tumors may spread to other parts of the body if left untreated. The three most common types of bladder cancer are; Urothelial carcinoma, Squamous cell carcinoma and Adenocarcinoma. Represented by the awareness color Marigold/Blue/Purple, bladder cancers are most often detected in patients by the presence of blood in the urine, frequent or burning sensation when urinating or lower back pain. Treatment options include; surgery, chemotherapy, immunotherapy and radiation. Treatment protocols are dependent upon the stage of the cancer, patient’s health, treatment preferences and potential side effects.  Bladder cancer mostly affects older people with an estimated 79,000 adults expected to be diagnosed with bladder cancer in the United States each year. With early detection the 10 year survival rate for bladder cancer is 70 percent.

Increased awareness has had a proven and positive effect on early diagnosis and treatment of various cancers and has resulted in a better educated and prepared patient. Utilizing this marketing approach the stigma once associated with cancer has been greatly diminished.

The Value of a Second Opinion Provides Alternative Treatment to a Cancer Patient

When faced with a cancer diagnosis, it becomes critical to find the right oncology center that will provide the appropriate medical treatment and emotion support to fight the battle. One Gettysburg resident, when faced with a stage-4 cancer diagnosis, found the right support at Gettysburg Cancer Center (GCC), a growing comprehensive cancer center.

Greg Wale received an initial oncology evaluation and treatment at another local oncology center in Gettysburg, Pennsylvania. The diagnosis showed that cancerous tumors had grown to 4 and 5 inches in diameter and had migrated to the liver, bone, thyroid glands and colon. Greg was just 57 year’s old and was told by oncologists that he had little time to live. There simply were no treatment options for his advanced stage of cancer. The disease, he was informed, had just progressed too far.

“At that point,” Greg says, “I went home, very down about things”. After several weeks of distress and depression over the state of his situation, he drew upon his faith and was “spiritually lead” to the Gettysburg Cancer Center (GCC), just down the block from where he had previously received the bad news. It was here that the centers principle oncologist, Dr. Shah, sat down with Greg to review his case. “I felt very comfortable here where there was a lot of very concerned people with caring hearts,” recounts Greg.

He immediately felt the staff at GCC wanted to help and he sensed that things were going to be different in this place where everyone seemed like family. Dr. Shah and his expert team designed a plan to attack his disease and provide as much time as possible for Greg’s future. With no guarantees, the team embarked upon an individualized course of treatment. After a couple of months, new tests revealed that the progression of the disease appeared to be slowing. According to Greg, “None of us knows how much time we have but it looks like I’m going to have more of it than what was told to me when I was first diagnosed thanks to Dr. Shah and this facility.”

For more than 25 years, Gettysburg Cancer Center has been committed to providing cancer care in a community-based setting close to home. The all-encompassing oncology and hematology programs provide a complete range of diagnosis and treatment. “Here at Gettysburg Cancer Center we understand that each patient and their disease are unique, requiring different approaches to insure the best possible outcome for each patient. Our family of caring and educated staff strives to provide insightful, compassionate care to all of our patients.” says Dr. Shah.

In this case, the value of a second opinion meant a new treatment option and more time for this cancer patient. To view the full patient testimonial: https://www.youtube.com/watch?v=448eg4F_SEg&feature=youtu.be.

Finding the Emotional Support You Need to Recover From Cancer

March Blog 1 Image

The discovery that you have cancer comes with many intense emotions, not only for the patient but also for close family members and friends. After the initial emotional and psychological effects of the news subsides, there is a realization that everything in your life is about to change. Daily routines, family roles and future plans will be determined by a regiment of treatments and medications that often pose additional physical symptoms and challenges to everyday living.

The support of family and friends during this process is critical to help the patient regain a sense of normalcy and maintain emotional stability. Efforts such as pier group support and individual therapy can help reduce distress and help cope with the personal emotions that come with a cancer diagnosis. Such support can play a critical role in determining the your clinical outcome.

Musa Mayer, a cancer survivor and patient advocate says, “Belonging to a group where you can discuss anything and everything is very freeing. You can talk about everything from medical treatments to lack of sexual interest, to fury at someone who has cut you off while driving. The loneliness and isolation that so many feel when they are going through the breast cancer journey can be helped, if not erased.”

Your doctor and their professional associates and nursing staff will also play a central role in providing coordination and support during treatment and recovery. “We have to look at a person’s medical care from a holistic perspective,” says Terri Ades, MS, APRN-BC, AOCN, director of cancer information at the American Cancer Society in Atlanta. Nurses are a patient’s greatest advocate.” Whether an oncology nurse or a nurse practitioner, these specially trained medical professionals become an important facilitator in managing overall care.

At his Gettysburg Cancer Center in Gettysburg, PA, Dr. Satish Shah, Medical Oncologist/Hematologist provides all-encompassing oncology and hematology programs with a complete range of diagnosis, treatment, and follow-up care. “It is our educated staff that set us apart from many other cancer centers,” says Dr. Shah, “We understand that every person is unique, each with their own set of psychological, emotional, and spiritual needs. Our team is dedicated to providing a caring environment for each individual patient and their families to insure the best possible outcome for their cancer treatment.”

In addition to your professional caregivers, The American Cancer Society has programs and services to help people with cancer and their loved ones understand cancer, manage their lives through treatment and recovery, and find the emotional support you need.

Grateful for Getting the Care Needed for a Long Life

Receiving news that you have contracted a life-threatening disease is an experience most of us hope will never occur. Most often normal, busy everyday activities put the possibility of suffering such an experience way back in our minds, relegating the concern to the “I’ll deal with that when I’m older and more likely to be a victim of such news.”

A projected 1.6 million Americans will be diagnosed with cancer this year, each one experiencing that moment of shock and disbelief long put away in the back of the mind. But while most of us are well aware of the risk of cancer diagnosis as we progress in age, the news that it can actual happen to us usually comes with a significant dose of disbelief and surprise, and when it comes at an early, usually healthier period in life, the news can be even more emotionally difficult to negotiate.

Matt Sheads, a healthy thirty something insurance executive in a famous small town in Pennsylvania lived an active, healthy lifestyle, performing numerous marathons, playing ice hockey and coaching local youth sports programs. His active, health conscious approach to life statistically identified him as one among many like him who would most likely NOT experience the news that he had a rare (for men) breast cancer. Breast cancer in men is rare with less than one percent of cancer cases of the disease developing in a thousand men. Matt soon learned that breast cancer in men is usually detected as a hard lump located underneath the nipple and areola. Unlike women, men don’t immediately associate the discovery with breast cancer and often delay further investigation and treatment.

“When you are diagnosed with cancer, it all sets in”, says Matt.” I have an 8-year-old son and I was very scared of the possibility of not seeing him graduate from school. It was a huge shock to me, I didn’t even know men got breast cancer. Oh, my gosh, how can it happen to me? I was born and raised in Gettysburg and love the small-town feel.” It was through the local Gettysburg Cancer Center that Matt was referred to nearby Washington D.C. for treatment of his rare disease. A large University hospital, Medstar Georgetown Hospital has the small town, individualized philosophy when it comes to cancer treatment. “I felt very welcome, that I was a part of a family, I felt like I was in my home town” recounts Matt.

After surgery and treatment, the prognosis for Matt is good. His disease is in remission and requires only annual visits and evaluations. He is back to doing the things he loves; coaching his son in sports, playing hockey, running and looking forward to being at his son’s graduation. His advice to other men, “If you find a problem, you find an issue, don’t self-diagnose… go find a specialist… and have a conversation with them.” Don’t delay getting the care you need to live a long life.

To view Matt Sheads video visit  https://www.youtube.com/watch?v=PUJatsj94hQ&feature=youtu.be.

Great Promise Lies Ahead for New Lifesaving Technologies

Image Image

Research into the effectiveness of stem cell and immunotherapy treatments for a wide range of chronic diseases is producing optimistic, if not yet proven, results. According to the California Institute for Regenerative Medicine, “there’s no limit to the types of diseases that could be treated with stem cell research. Given that researchers may be able to study all cell types via embryonic stem cells, they have the potential to make breakthroughs in any disease.” In recent year’s stem cell-based therapies have been initiated but the results of those trials may take several years of testing and study to render the treatments safe and effective.

Physicians at Emory Orthopedics & Spine Center in Atlanta are among a select group of physicians around the country to offer Stem Cell therapy and other regenerative medical therapies for the relief of osteoarthritis (OA) pain and chronic tendonitis. The non-surgical procedure uses the patient’s own stem cells taken from the body and injected into the effected joint or tendon to repair damaged tissue. Osteoarthritis is the most common form of arthritis in the U.S., affecting nearly 27 million adults. At other medical centers around the country, skin stem cells have been used to grow skin grafts for patients with severe burns on very large areas of the body. Only a few clinical centers are able to carry out this treatment and it is usually reserved for patients with life-threatening burns. In Europe a new stem-cell-based treatment to repair damage to the cornea after an injury like a chemical burn, has received conditional marketing approval.

Blood-forming stem cells in the bone marrow were the first stem cells to be identified. This life-saving technique has helped thousand’s  worldwide who had been suffering from blood cancers, such as leukemia. In addition to their current use in cancer treatments, research suggests that bone marrow transplants will be useful in treating autoimmune diseases and in helping people tolerate transplanted organs.

Autologous, stem cells harvested from the same person who will get the transplant, and Allogeneic stem cells that come from a matched related or unrelated donor are the two main types of treatments currently approved for use. Combined with very high doses of chemotherapy, and often radiation therapy, the combined treatment has been shown to kill cancer cells in the patient’s bone marrow. Given by transfusion, the transplanted stem cells replace those that were destroyed. This application is among the most widely used stem cell treatment used to treat diseases and conditions of the blood and immune system.

In England, researchers have made exciting new findings that could offer a means of fighting resistance to treatment for people with esophageal cancer. Resistance to radiotherapy is a major stumbling block in the treatment of this cancer. The team of scientists, which incorporated specialists from Trinity, St. James’s Hospital Dublin, the Coombe Women and Infant’s University Hospital and the University of Hull in the UK, have published their significant findings in the international peer-reviewed journal Oncotarget. “This work is extremely important in understanding why tumors are inherently resistant to radiotherapy, and how they can acquire resistance. Our findings strongly suggest that it is the cancer stem cell population that we need to destroy if treatment is going to be effective in our esophageal cancer patients,” said Dr Maher.

Doctors in London say they have cured two babies of leukemia in the world’s first attempt to treat cancer with genetically engineered immune cells from a donor. The experiments, which took place at London’s Great Ormond Street Hospital, raise the possibility of off-the-shelf cellular therapy using inexpensive supplies of universal cells that could be dripped into patients’ veins on a moment’s notice. The infants, ages 11 and 16 months, each had leukemia and had undergone previous treatments that failed, according to a description of their cases published in Science Translational Medicine. Waseem Qasim, a physician and gene-therapy expert who led the tests, reported that both children remain in remission.

In the United States, China and around the world, scientists are racing to apply gene editing, stem cell and other immunotherapy treatments to provide improved treatments for cancer and other diseases. Utilizing the current path to approval it will be years before the new discoveries become commonplace, but the research must continue to advance if we are to realize the benefits of new lifesaving technologies.

human body

Clinical Trials; Offering New and Advanced Treatment Options to Cancer Patients

Once seen as a last chance attempt for cancer patients to turn back the progression of their disease, clinical trials are becoming many sufferers initial treatment option. Clinical trials are research studies that involve humans to aid and assist doctors and researchers in developing new techniques to prevent, treat, diagnose and manage side effects for cancer patients. Trial participants receive either the standard of care or the new medication or procedure that is under study. As a participant, patients receive the latest drugs protocols and treatment procedures available to discover ways to improve the quality of life for those afflicted with the disease. While the dynamics of clinical trials pose some additional risk when compared with long used methods, clinical trials can offer an additional measure of hope for remission or a cure.

medicine

Advancements in Chemotherapy & Alternative Therapies

The practice of utilizing chemical therapy (Chemotherapy or Chemo) for the treatment of cancer began in the 1940’s and remains a fundamental treatment for many cancer types. Concerns over Germany’s devastating use of mustard gas during World War I, led two pharmacologists from the Yale School of Medicine, Louis S. Goodman and Alfred Gilman, to discover nitrogen mustard, as an effective treatment for cancer. Given the poisonous origin of chemotherapy, patients receiving these agents experienced severe side-effects that produced limitations on the doses and the benefits of the treatment. The ability to manage these toxicities and their negative side effects became crucial to the future success of cancer chemotherapy.